Literature DB >> 8002262

Helicobacter pylori and gastro-oesophageal reflux disease--a prospective study.

H J O'Connor1, K Cunnane.   

Abstract

In a prospective evaluation of the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease (GORD), 93 consecutive patients (47 female: 46 male: mean age, 46 years: range 13-93) with symptoms and endoscopic evidence of GORD were studied. A total of 50 patients (54%) were H. pylori-positive on gastric antral biopsies. No significant correlation was detected between H. pylori status and grade of oesophagitis. The prevalence of H. pylori infection showed a gradual increase with age. Of 64 patients with a hiatal hernia, 28 (44%) had histological evidence of H. pylori infection of the hernia mucosa; 27 of these patients (96%) had associated H. pylori in the gastric antrum. Of the 36 patients whose hiatal hernia was H. pylori-negative, only 6 (17%) had antral H. pylori (P < 0.001). Of the 8 patients found to have Barrett's oesophagus, only 1 had H. pylori detected on the Barrett's mucosa. Our results do not support the presence of a significant association between H. pylori infection and GORD.

Entities:  

Mesh:

Year:  1994        PMID: 8002262     DOI: 10.1007/BF02942830

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  24 in total

1.  Helicobacter pylori: has it a part in the lesion of the gastroesophageal reflux?

Authors:  S Francoual; P Lamy; Y Le Quintrec; J Luboinski; J C Petit
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

Review 2.  Chronic gastritis--a pathogenetic approach.

Authors:  J I Wyatt; M F Dixon
Journal:  J Pathol       Date:  1988-02       Impact factor: 7.996

3.  Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease.

Authors:  E H Cheng; P Bermanski; M Silversmith; P Valenstein; H Kawanishi
Journal:  Arch Intern Med       Date:  1989-06

4.  Gastric emptying in patients with gastroesophageal reflux.

Authors:  R W McCallum; D M Berkowitz; E Lerner
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

5.  Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus.

Authors:  G Paull; J H Yardley
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

6.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

7.  Solid and liquid gastric emptying in patients with gastro-oesophageal reflux.

Authors:  G J Maddern; B E Chatterton; P J Collins; M Horowitz; D J Shearman; G G Jamieson
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939

8.  Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both?

Authors:  S Sloan; A W Rademaker; P J Kahrilas
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

9.  Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus.

Authors:  R J Loffeld; B J Ten Tije; J W Arends
Journal:  Am J Gastroenterol       Date:  1992-11       Impact factor: 10.864

10.  Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying?

Authors:  M Wegener; G Börsch; J Schaffstein; C Schulz-Flake; U Mai; F Leverkus
Journal:  Am J Gastroenterol       Date:  1988-07       Impact factor: 10.864

View more
  18 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 2.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

3.  Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Authors:  T Rokkas; S D Ladas; C Liatsos; E Panagou; A Karameris; S A Raptis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

4.  Corpus gastritis is protective against reflux oesophagitis.

Authors:  H B El-Serag; A Sonnenberg; M M Jamal; J M Inadomi; L A Crooks; R M Feddersen
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

5.  A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic.

Authors:  A Heaney; J S Collins; R G Watson; R J McFarland; K B Bamford; T C Tham
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

6.  Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.

Authors:  Y Yamaji; T Mitsushima; H Ikuma; M Okamoto; H Yoshida; T Kawabe; Y Shiratori; K Saito; K Yokouchi; M Omata
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 7.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

Review 8.  Trends in the management of gastro-oesophageal reflux disease.

Authors:  J M Lee; C A O'Morain
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

9.  Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.

Authors:  E F Verdú; D Armstrong; J P Idström; J Labenz; M Stolte; G Dorta; G Börsch; A L Blum
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

Review 10.  Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?

Authors:  J M Lee; C A O'Morain
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.